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UNDERSTANDING THE HEALTH OF
POPULATIONS AND OF INDIVIDUALS
Hickman and colleagues [1] suggest that we need a trans-
lational approach in addiction science whereby basic or
bench science combine with neuroscience and social
science to provide us with a better understanding of how
alcohol and opiate use combine to produce a risk of over-
dose. The central argument of Hickman and colleagues’
paper is inarguable. There is little question that scientific
knowledge needs to advance through a combination
of approaches and that epidemiology and molecular
biology, to take just two examples, both have something
different, and in many cases complementary, to contrib-
ute to our understanding of the production of disease.
There is, however, an important distinction to be made
between the goals of epidemiological and molecular
studies that is blurred in Hickman and colleagues’ paper.
I will elaborate here on this distinction and why it is
central to how we tackle important research questions in
addiction science.
The goals of epidemiological studies (or population-
based studies in general) and molecular studies (or
laboratory-based studies in general) are fundamentally
different. Epidemiology uses methods that concern popu-
lation averages and is best suited to provide us with esti-
mates of the occurrence of disease, or of the determinants
of disease at the population level [2]. Hence, when a par-
ticular factor is identified as a determinant or a cause of
disease through a series of epidemiological studies, this
shows us that at a population level, factor A is a determi-
nant of outcome B. Unfortunately, this tells us very little
about the likelihood that a particular individual who is
exposed to factor A will indeed develop outcome B. It can
be shown quite readily that most of the typical measures of
association documented in epidemiological studies (e.g.
relative risks in the ranges of 2–4) are practically useless in
determining an individual’s likelihood of disease or, put
technically, what the positive predictive value of factor A
for outcome B is for any given individual [3]. This is, of
course, quite different from the methods and intent of
molecular studies, be they basic science or animal simula-
tion models. These studies attempt to understand the
precise molecular interactions that result in pathophysi-
ological changes that we then recognize as disease. This
understanding of molecular processes is, in a perfect
world, applicable to an individual whose molecular struc-
ture we can map and completely understand.
Therefore, epidemiological and molecular studies are
fundamentally asking different questions. The former are
best suited to ask: ‘what are the factors that predict popu-
lation rates of health and disease?’, while the latter are
best suited to ask: ‘how do specific factors interact within
individuals to initiate, or influence, pathophysiological
processes?’. This distinction is critical and adds nuance
to the essential argument being made by Hickman and
colleagues [1]. It is important to adopt a translational
approach in addiction science not because epidemiologi-
cal studies cannot provide an answer conclusively to
the alcohol-opiate problem raised by Hickman and col-
leagues but, rather, because epidemiological methods can
only tackle one aspect of this problem—that concerned
with the production of overdose rates in the population.
We need molecular studies to help us understand patho-
physiology within individuals, another equally important
aspect of the same problem that is simply not addressed
by epidemiological methods.
This reasoning suggests, then, that Hickman and
colleagues’ [1] criticism of observational studies in
epidemiology is somewhat misplaced. The issue is not
whether observational studies are ‘good methods’, but
rather whether they are applied appropriately to provide
valuable results to the questions of interest. While there
is no doubt that there have been findings from epidemio-
logical studies that have been shown by experimental
studies to have been incorrect, there have also been
many observations drawn from molecular and bench
studies that have also been shown later to be incorrect
through other studies. I note this distinction not simply
to quibble about the relative merits of one method
versus another, but rather to note that different
methods, be they molecular or epidemiological, may
well have merit in pursuit of specific questions and that
there is little scientific reason to argue that some
methods are ‘good’ and others ‘bad’.
Recognizing this difference is of more than academic
importance. Hickman and colleagues [1] suggest that a
better understanding of the alcohol–opiate interaction
would suggest different health education campaigns.
Perhaps. But more fundamentally, educational cam-
paigns are but one type of intervention and I suggest
that there might be different types of interventions that
are suggested by different research approaches. The
epidemiological demonstration that the coincident pres-
ence of alcohol and opiates is associated with greater
population rates of drug overdose suggests population-
level educational interventions to highlight the dangers
of the concomitant use of alcohol and opiates, regard-
less of the precise molecular mechanism underlying this
relation. Conversely, molecular evidence that alcohol
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and opiates act synergistically as respiratory depressants
might suggest a pharmacological intervention that
reverses the respiratory suppressant effect of either or of
both drugs together that can be made available to indi-
viduals who may use both drugs concurrently.
In sum, I commend Hickman and colleagues [1] on
raising the importance of a multi-disciplinary approach
to addiction science. I could not agree more. It is one
of the most appealing aspects of this area of research
that there are so many fascinating scientific questions,
ranging from molecular to population-level questions.
However, we need different methods to address these dif-
ferent questions. Greater precision in understanding the
questions we are asking will help us to use the tools at our
disposal more efficiently [4].
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ALCOHOL AND THE RISK OF OVERDOSE
DEATH FROM HEROIN
Fatal intoxications are by far the most common reason for
the excess mortality in drug users, followed by various
somatic disorders, suicide, trauma and homicide [1].
Research in this area may help to reduce mortality in
drug dependence. One of the apparent risk factors in fatal
overdose are polyintoxications, and especially the role of
alcohol. We read with interest the article from Hickman
et al. [2], which suggests that animal models could
provide evidence for pharmacodynamic or pharmakoki-
netic interactions between alcohol and opioids which
should be corroborated within clinical challenge and epi-
demiological studies.
While some issues on this subject are clear, many are
open for debate. In their recent publication, Darke et al.
[1] have discussed most of the issues concerning mortal-
ity among illicit drug users and this paper is an an out-
standing and highly informative research monograph.
Hickman et al. [2] state with reason that many studies
have reported that alcohol is present in half or more cases
and that there is an inverse relationship between blood
alcohol and blood morphine concentrations [3]. The fact
that central nervous system depressants such as alcohol
increase the risk for fatal overdose by respiratory depres-
sion is not surprising. One of the more interesting ques-
tions is the chronological relationship between alcohol
and heroin intake. There is some evidence [3,4] that the
risk is highest when using heroin following the consump-
tion of alcohol, and not the other way around, but this
has to be studied in more detail. There is also evidence for
a much faster than usual respiratory depression after
heroin consumption in alcohol-intoxicated individuals
[5]. A possible explanation might be a decreased meta-
bolization of monoacetylmorphin to morphin in the
presence of high blood alcohol levels [5]. This question
can be answered only through a translational research
approach.
Both from epidemiological and clinical perspectives, it
seems noteworthy to point out that the number of indi-
viduals with alcohol intoxications in methadone main-
tenance is lower than in heroin users. Two studies
published in Addiction emphasize this: Bryant et al. [6]
examined 7451 overdose deaths in New York City
between 1990 and 1998; 1024 were methadone-
induced overdose deaths and 4267 heroin-induced
deaths. Alcohol was detected in 10.9% of methadone-
induced overdose deaths but in 72% of heroin-induced
deaths. Similarly, Shah et al. [7] studied 1120 drug over-
dose deaths in New Mexico. Alcohol was present in
20.3% of the methadone-related and 30.6% of the non-
methadone-related deaths. These studies do not provide
information about level of blood alcohol and heroin con-
centration or the chronological inter-relationship. These
issues can be studied only in a translational research
approach, not by only analysing toxicological data.
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